The Real-World Lifetime Economic Burden of Urothelial Carcinoma by Stage at Diagnosis.

Abdalla Aly,Courtney Johnson,Yunes Doleh,Viktor Chirikov,Marc Botteman,Rahul Shenolikar,Arif Hussain

Journal of clinical pathways : the foundation of value-based care（2020）

引用 8|浏览10

暂无评分

摘要

UC continues to be a costly cancer with stage III patients having highest lifetime costs. Hospitalizations drive most of the lifetime costs across all stages; most of these hospitalizations did not involve costs related to cystectomy. Treatment plans requiring shorter and fewer hospitalizations may lessen the economic burden of UC.

查看译文

关键词

Immunotherapy,SEER-Medicare,administrative claims,bladder cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要